Viatris
Gaurav Singh is an experienced professional in quality investigations within the pharmaceutical industry, currently serving as General Manager of Global Quality Investigations at Viatris since November 2020. Gaurav's expertise includes risk-based site selection, strategic sampling planning, audit report preparation, and conducting complex investigations to identify root causes and implement corrective actions. With a strong background in quality control from previous roles at Mylan Laboratories Limited, Wockhardt Ltd., and Ranbaxy, Gaurav has successfully managed Out-of-Specification investigations and conducted compliance audits across various manufacturing sites. Gaurav holds a Master’s degree in Analytical Chemistry from Gurukula Kangri Vishwavidyalaya and an Advanced Diploma in Drug Regulatory Affairs from Jamia Hamdard.
This person is not in any teams
This person is not in any offices
Viatris
42 followers
Viatris is a new kind of global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including a global workforce of approximately ~45,000, Viatris aims to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.